glasslewis.com
BioLogics and Bioepis: The Scandal Surrounding Samsung's Succession
With the conviction of Samsung BioLogics Co., Ltd.,(“BioLogics”), longstanding suspicions surrounding Samsung Group (the “Group”), BioLogics’ parent and South Korea’s biggest family-ruled conglomerate, have once again risen to the surface. On November 13, 2018, the Securities and Futures Commission (“SFC”), Korea’s financial regulator, suspended BioLogics shares from trading, and imposed a fine of KRW 8 billion.